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Social media quote
Women with congenital heart disease have a higher risk of preterm birth as well as giving 
birth to a small for gestational age infant at all maternal ages. These two risk factors do not, 
however, seem to potentiate each other.
Link to figure 2. 
Synopsis
Study question
Is the effect of age on the risk of preterm birth (PTB) and small for gestational age (SGA) 
higher among women with congenital heart disease?
What´s already known? 
Women with congenital heart disease have a higher risk of PTB and SGA. Advanced 
maternal age (≥35 years) likewise increases the risk of PTB and SGA, probably explained by 
poorer cardiovascular status. However, knowledge about whether these two risk factors 
potentiate each other is not well described.
What this study adds 
Women with congenital heart disease have a higher risk of PTB and giving birth to a SGA 
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Abstract
Background: Women with maternal congenital heart disease have a higher risk of preterm 
birth (PTB) and giving birth to a small for gestational age (SGA) infant. Advanced maternal 
age (≥35 years) likewise increases the risk of PTB and SGA, probably explained by poorer 
cardiovascular status.  It is likely that advanced maternal age is particularly detrimental in 
women with congenital heart disease. 
Objectives: We aimed to determine whether the pattern of higher risk of PTB and SGA with 
higher maternal age varied among women with and without congenital heart disease. We 
hypothesized that the effect of age is higher among women with congenital heart disease. 
Methods: We did a cohort study using Danish nation-wide registers Births from 1997-2014 
were included. Cox regressions were used to estimate hazard ratios (HR) for PTB and SGA. 
Universal and congenital heart disease specific references was used for comparison.
Results: We included 932,772 births among 548,314 women. HRs of PTB and SGA were 1.55 
(95% confidence interval [CI] 1.37, 1.77) and 1.43 (95% CI 1.29, 1.58) in women with 
congenital heart disease as compared to women without. For both PTB and SGA, HRs were 
higher for women 35 years as compared to women aged 25-29 years. HRs of PTB and SGA 
were higher among women with congenital heart within all strata of maternal age as 
compared to women without (e.g. 2.46, 95% CI 1.18, 5.14 vs. 1.63, 95% CI 1.56, 1.70) for 
SGA for women aged 40-44 years). The pattern of higher risk of PTB and SGA with higher 
maternal age was, however, similar among women with and without congenital heart 
disease. 
Conclusions: Women with congenital heart disease had a higher risk of PTB and giving birth 
to an SGA infant at all maternal ages. These two risk factors did not, however, seem to 
potentiate each other.
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Due to advances in diagnosis and treatment more people with congenital heart disease now 
survive into adulthood and more women are reaching the childbearing age.1 In the United 
States, e.g., the rate of deliveries among women with congenital heart disease increased 
from 6.4 per 10,000 deliveries in 2000 to 9.0 per 10,000 in 2010.2 These women will in 
general experience more cardiac, obstetric and neonatal complications.2-6 
Women in the Western world tend to delay motherhood and give birth at more advanced 
ages.7, 8 Advanced maternal age (≥35 years) has been associated with higher risk of fetal 
death, preterm birth (PTB) and giving birth to infants born small for gestational age (SGA).9 
The mechanism behind this increase is poorly understood but has partly been explained by 
poorer cardiovascular status among older women which impacts placental function.10
Due to poorer cardiovascular status among women with congenital heart disease, it is likely 
that advanced maternal age is particularly detrimental in these women and they therefore 
experience a greater effect of age with higher maternal age as compared to women without 
congenital heart disease. However, the consequence of the combination of congenital heart 
disease and advanced maternal age in relation to adverse neonatal outcomes has not been 
well described. 
To provide the best advice for women with congenital heart disease more knowledge about 
the combined effects of congenital heart disease and advanced maternal age is needed. 
Therefore, we aimed to determine whether the pattern of higher risk of PTB and SGA with 
higher maternal age varied among women with and without congenital heart disease. Due 
to poorer cardiovascular status among women with congenital heart disease we 
hypothesised that the effect of age is higher among women with congenital heart disease as 
compared to women without congenital heart disease.
METHODS
The study is a cohort study with nation-wide prospectively collected register data. Data from 
the Danish National Birth Register,11, 12 the Danish National Patient Register,13, 14 and the 
Danish Civil Registration System15 were linked at an individual level, using the unique 
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Study population
The study population consisted of women born in Denmark giving birth to a single child in 
Denmark between 1997 and 2014 (n=952,882). Information about maternal age was 
obtained from the Danish Civil Registration System.15 Maternal age was assessed at 
inclusion and estimated based on date of delivery, gestational age and maternal date of 
birth.  We restricted the study population to births among women aged 15 to 44 years. All 
women carrying a pregnancy to 22 weeks of completed gestation (154 days) were included 
in the cohort.12 The final study population consisted of 932,772 births.  Figure 1 shows the 
study inclusion and exclusions. 
Maternal congenital heart disease
Information about maternal congenital heart disease was obtained from the Danish 
National Patient Register, which is a population-based administrative register holding 
information on all hospital admissions since 1977.13, 14 All women with a diagnosis of 
congenital heart disease (ICD-10; Q20-Q26, ICD-8; 746-747) between 1977 and 2015 were 
included except ICD-10 Q26.5-Q26.6 and ICD-8 746.7 and 747.5-747.9, which are not 
specific for congenital heart disease. To increase the positive predictive value of the 
diagnoses of congenital heart disease we excluded individuals with e.g. unspecific diagnoses 
using an algorithm previously described.17 We included women diagnosed before, during, 
and after pregnancy under the hypothesis that underlying congenital heart disease affected 
the pregnancy and its outcome irrespective of whether the disease was diagnosed at the 
time of delivery. Based on guidelines from the European Society of Cardiology, congenital 
heart disease was categorized into simple, moderate and complex.18 Women with more 
than one diagnosis were categorised according to the more severe diagnosis.
Preterm birth and small for gestational age
Information about birthweight and gestational age was obtained from the Danish Medical 
Birth Register.11, 12 PTB was defined as giving birth to a liveborn child before 37 weeks of 
completed gestation. Births with implausible combinations of birthweights and gestational 
age according to standards from Alexander et al.19 were excluded (n=602). SGA was 
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percentile of standard references given by Marsál et al.20 During the study period, the 
estimation of gestational age was based on best clinical estimates based on ultrasound, last 
menstrual period and judgment of the child.  
Covariates
Ethnicity, parity, socio-economic position and calendar year were identified as potential 
confounders a priori using Directed Acyclic Graphs (eFigure 1). Information about ethnicity 
was obtained from the Danish Civil Registration System and grouped into Western and non-
Western according to Statistic Denmark.21 Information on parity was obtained from the 
Danish Medical Birth Register and after logical cleaning grouped into nulli-, primi- and 
multiparous. 
Socioeconomic position was assessed by level of education, which has shown to be a strong 
socioeconomic predictor of the risk of both PTB and SGA in Denmark.22, 23 Level of education 
was assessed as the highest ongoing or attained education. Information about educational 
level 1st of October the year preceding each birth was obtained from the Danish Education 
Register.24 Education was classified according to the International Standard Classification of 
Education System (ISCED 2011) and categorised into four groups; low education (pre-
primary, primary and lower secondary; levels 1-2), medium (upper secondary and 
postsecondary; levels 3-4) short and medium cycle higher education (short-cycle tertiary 
and Bachelor´s; levels 5-6)  and long-cycle higher education (Master´s or higher; levels 7-8). 
Age was categorized into five groups; 15-24, 25-29, 30-34, 35-40 and 40-44 years. Calendar 
year was grouped into 5-year bands.
Statistical analysis
For the descriptive analysis, median and interquartile range (IQR) was used for continuous 
variables and counts with proportions was used for categorial variables.  The association 
between congenital heart disease and, respectively, PTB and SGA was estimated using a Cox 
proportional hazard models with gestational age as underlying time scale. For PTB, the 
follow-up ended at birth or after 258 days of gestation whichever came first. Pregnancies 
resulting in stillbirth were censored at the time of stillbirth or after 258 days. When 
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stillbirths were censored at the time of births. Adjustment was made for calendar year, 
ethnicity, parity and educational level. Some women contributed with more than one birth 
to the cohort. To account for the clustered structure of data, a cluster-robust standard error 
estimator was used. Results were presented as hazard ratio (HR) with 95% confidence 
interval (CI).
We hypothesised that the effect of age on the risk of PTB and SGA was higher among 
women with congenital heart disease as compared to women without congenital heart 
disease. Therefore, we tested the possible multiplicative interaction between maternal age 
and congenital heart disease on the risk of PTB and SGA, respectively. The joint effect of 
maternal age and congenital heart disease was tested by including the interaction term in 
the model without the main effects using a universal reference group (women without 
congenital heart disease aged 25-29 years). The relative excess risk due to interaction (RERI) 
and 95% CI was calculated to assess effect modification on an additive scale.25 Lastly, 
analyses were conducted within strata of congenital heart disease. Linear trends were 
tested by treating age categories as a continuous variable. The proportional hazard 
assumption was evaluated visually using log-log plots with no violations detected. 
Missing data
The amount of missing data was low (<2.0 %) and observations with missing data on the 
observed variables were excluded from the analyses (Figure 1). 
Sensitivity analysis
To examine the robustness of our results several sensitivity analyses were conducted. 
Firstly, the analysis was restricted to nulliparous women to account for selected fertility 
based on outcomes from the first pregnancy. Secondly, we conducted an analysis where 
preterm stillbirths and SGA stillbirths were included as events instead of getting censored. 
Lastly, we conducted an analysis where women diagnosed with a complex congenital heart 
disease were excluded to examine whether the association was driven by the more severely 
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The study was approved by the Danish Data Protection Agency (2015-57-0008, 
no.16/48885). According to Danish law, register-based studies do not need ethical approval. 
All data were provided by Statistic Denmark.
RESULTS
Birth and maternal characteristics
A total of 3,688 single births were observed among 2,193 women with congenital heart 
disease. The proportion of births of women with congenital heart disease increased from 
0.31% in the start of the study period to 0.52% at the end. Most of the women diagnosed 
with congenital heart disease were diagnosed with a simple defect (60.3%) of which atrial 
septal defect and ventricular septal defect constituted the main defects. Complex diagnoses 
constituted 10.4 % of the diagnoses. Women with congenital heart disease were younger 
when giving birth and more were nulliparous as compared to women without congenital 
heart disease (Table 1). 
The median gestational age was 280 days (IQR 273-287). Mean follow-up time, from 
inclusion at 154 days of gestation to censoring or birth, was 104 days (range 1-105) for PTB 
and 126 days (range 1-161) for SGA. The overall proportion of PTB was 5.0% (n=46,540) and 
SGA 10.4% (n=93,723). 
Main effects of congenital heart disease and maternal age
Women with congenital heart disease had a higher risk of both PTB and SGA as compared to 
women without congenital heart disease with adjusted HRs (HR) of 1.55 (95% CI 1.37, 1.77) 
and 1.43 (95% CI 1.29, 1.58). 
There was a higher risk of PTB with higher maternal age. In comparison to women aged 25-
29 years, the HRs of PTB were 0.90 (95% CI 0.88, 0.93), 1.07 (95% CI 1.05, 1.10), 1.28 (95% CI 
1.24, 1.32) and 1.56 (95% CI 1.47, 1.66) for women aged <25, 30-34, 35-39 and 40-44, 
respectively. Likewise, the risk of giving birth to a child born SGA was higher with higher 
maternal age. In comparison to women aged 25-29 years, the HRs of SGA were 0.93 (95% CI 
0.91, 0.95), 1.11 (95% CI 1.09, 1.12), 1.31 (95% CI 1.28, 1.34), and 1.63 (95% CI 1.56, 1.71) 
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Combined effect of congenital heart disease and maternal age
Women with congenital heart disease had a higher risk of PTB at all maternal ages. The 
pattern of higher risk from maternal age 25-29 years and above did not diverge between 
women with and without congenital heart disease (p of multiplicative interaction=0.71, p of 
additive interaction=0.62). In comparison to women aged 25-29 years without congenital 
heart disease, women with congenital heart disease aged 35-39 years and 40-44 years had 
an HR of 1.72 (95% CI 1.18, 2.51) and 3.38 (95% CI 1.44, 7.90), respectively (Figure 2, eFigure 
2 and eTable1). Crude estimates for women ≥30 years were somewhat lower. Adjustment 
for confounders increased HRs among older women, e.g. 18% for women with congenital 
heart disease aged 35-39 years. Adjustment for educational level and parity increased 
estimates the most. 
Women with congenital heart disease had a higher risk of giving birth to a child born SGA at 
all maternal ages. As for PTB the pattern of higher risk of SGA from maternal age of 30-34 
years was similar among women with and without congenital heart disease (P of 
multiplicative interaction=0.55, P of additive interaction=0.63). In comparison to women 
aged 25-29 years without congenital heart disease, women with congenital heart disease 
aged 35-39 and 40-44 years had HRs of 1.68 (95% CI 1.23, 2.28) and 3.71 (95% CI 1.80, 7.63), 
respectively (Figure 2, eFigure2 and eTable1).
Sensitivity analysis
The risk of PTB among women 35-44 years with congenital heart disease was less clear with 
an HR of 0.68 (95% CI 0.25, 1.82) when restricting the analyses to nulliparous women 
(eFigure 3), whereas the HR of SGA was essentially the same as for the whole population of 
women with congenital heart disease (eFigure 3). When a preterm stillbirth or an SGA 
stillbirth was included as events instead of getting censored results were essentially similar 
(eFigure 4). When women diagnosed with complex congenital heart disease were excluded 
from the analyses the same pattern was seen with a higher risk of both PTB and SGA with 
higher maternal age. Likewise, the pattern of higher risk was similar between women with 
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Principal findings
In this nation-wide register-based study we found that women with congenital heart disease 
had a higher risk of PTB and giving birth to an SGA infant at all maternal ages. However, 
these two risk factors did not seem to potentiate each other.
Strengths of the study
Using national population-based registries based on prospectively collected data enables 
inclusion of all deliveries as well as all women diagnosed with congenital heart disease in 
Denmark which limits the risk of selection bias related to both deliveries and congenital 
heart disease. To limit the risk of information bias, all diagnoses of congenital heart disease 
were validated using an algorithm previously described.6, 17 
A further strength of the study is the adjustment for socioeconomic position by educational 
level. Inability to adjust for socioeconomic position may give a spuriously high risk among 
younger women and a spuriously low risk among older women.26  We assessed educational 
level as expected level of education in case it was higher than the attained level of 
education to overcome a dependency between age and education among younger women.
We find the results to be robust since similar findings were found in the sensitivity analyses. 
The HR for PTB among nulliparous women, however, was lower. We find it plausible that 
this finding is due to chance since the sample is very small; however, we cannot rule out, 
that the lower HR is due to a natural selection - that women with congenital heart disease 
who have their first child at the age ≥35 years are healthier, have a better cardiovascular 
status etc. and therefore have a lower risk. 
Limitations of the study
Even though we have conducted a nation-wide study with a large study sample the number 
of women of more advanced age among women with congenital heart disease is still small. 
However, despite the small number of women we found a higher risk of giving birth to a 
SGA infant among women with congenital heart disease of more advanced age and a clear 
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Women who are foreseen to be at high risk during pregnancy and delivery may due to 
counselling decide not to become pregnant. Thus, the group of women with congenital 
heart disease may only include the women with best cardiovascular conditions. 
Furthermore, the amount of induced abortion is lower among women with congenital heart 
disease27, 28 as compared to the general population, which is suggested to reflect a different 
psychological or social situation for women with congenital heart disease.28  This could 
further support the fact that women with congenital heart disease who end up pregnant in 
general are a more selected group than the general population of pregnant women and 
despite a poorer cardiovascular status might be more selected on other parameters of 
importance for PTB and SGA. 
Congenital heart disease is a heterogeneous group and risk might differ between different 
subgroups of congenital heart disease. However, due to the low amounts of women with 
congenital heart disease who have had children at advanced maternal age we are not able 
to divide into further subgroups. However, excluding the most complex diagnoses from the 
analyses essentially gave the same findings indicating that the associations are not purely 
driven by the most severely affected women. 
Lastly, we cannot rule out that we have missed some women diagnosed with a congenital 
heart disease before 1977. However, for those women not to be included in our sample 
they should have been diagnosed before 1977 without having a single contact to the 
hospital with a diagnosis of congenital heart disease after 1977 even during pregnancy and 
delivery. We do not consider this to be very likely; however, not impossible. We would 
expect such bias to lead towards null.  
Interpretation
In the general population women of advanced maternal age have a higher risk of both PTB 
and SGA.9 Only a single study has investigated the association between maternal age, 
congenital heart disease and neonatal outcomes28 while other studies have included 
maternal age as a predictor of neonatal outcomes.3, 29 Furenäs et al.28 did not find a higher 
risk among women >35 years as compared to women ≤35 years. The study however was 
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age ranged from 15-35 years in which the risk is known to increase and therefore might 
attenuate the contrast between women with the lowest risk and women above 35 years, 
especially when socioeconomic position is not accounted for.  
To some extend it is questioned whether the effect of maternal age on adverse neonatal 
outcome is due to biology or due to selection.30 Advanced maternal age has been associated 
with a range of adverse pregnancy outcomes showing the same shape of increase in risk 
across different outcomes9, 26, 31, 32 which might indicate a biologic explanation. In our study 
we likewise demonstrate a similar higher risk of both PTB and SGA with increasing age. 
Furthermore, the association is similar between women with and without congenital heart 
disease indicating that the biological explanation is the same in both groups. Whereas the 
selection into motherhood at more advanced ages, as touched upon previously, might be 
different between the general population and among women with congenital heart disease. 
The underlying biologic mechanism proposed to modify the association between advanced 
maternal age and adverse neonatal outcomes is an abnormal placental function due to 
accelerated placental aging among older women.10 Women with congenital heart disease 
have a disturbed uteroplacental blood flow which has been suggested to cause the 
increased risk of giving birth to an SGA infant among women with congenital heart 
disease.33, 34 Our results indicate that these processes, however, might act independent and 
do not work in synergy. 
  
In our study population women with congenital heart disease were on average younger 
when giving birth as compared to women without congenital heart disease. This is similar to 
what was found in a Swedish population based study35, whereas others have reported 
similar mean age across women with and without congenital heart disease.2, 4, 28, 36 The 
lower age may be due to counselling by medical staff or because young people living with a 
congenital heart disease feel more mature and appreciate life in another way than peers.37 
This could cause them not extend their youth to the same extend as seen in the general 
population where readiness to become a parent is also highly associated with fulfilling other 
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While we in consistency with other studies show an increased risk of common pregnancy 
complications in women with congenital heart disease, this study also demonstrates that 
the risk is not higher than 10 years older women without congenital heart disease. The 
study indicates that women with congenital heart disease can ‘normalise’ their risk for PTB 
and SGA by having children at younger age.
Conclusions
Women with congenital heart disease had a higher risk of PTB and giving birth to a SGA 
infant at all maternal ages.  The pattern of higher risk with increasing maternal age 
apparently seemed to be similar among women with and without congenital heart disease. 
Since even some of the young women with congenital heart disease had a higher risk of 
neonatal complications as compared to women without congenital heart disease, it might 
be of importance to advice these women to have children at a younger age to minimize the 
risk of adverse neonatal outcomes.
References
1. Khairy P, Ionescu-Ittu R, Mackie AS, Abrahamowicz M, Pilote L, Marelli AJ. Changing 
mortality in congenital heart disease. J Am Coll Cardiol. 2010; 56:1149-1157.
2. Thompson JL, Kuklina EV, Bateman BT, Callaghan WM, James AH, Grotegut CA. Medical 
and Obstetric Outcomes Among Pregnant Women With Congenital Heart Disease. 
Obstet Gynecol. 2015; 126:346-354.
3. Owens A, Yang J, Nie L, Lima F, Avila C, Stergiopoulos K. Neonatal and Maternal 
Outcomes in Pregnant Women With Cardiac Disease. J Am Heart Assoc. 2018; 
7:e009395.
4. Warrick CM, Hart JE, Lynch AM, Hawkins JA, Bucklin BA. Prevalence and descriptive 
analysis of congenital heart disease in parturients: obstetric, neonatal, and anesthetic 
outcomes. J Clin Anesth. 2015; 27:492-498.
5. Roos-Hesselink JW, Ruys TP, Stein JI, Thilen U, Webb GD, Niwa K, et al. Outcome of 
pregnancy in patients with structural or ischaemic heart disease: results of a registry of 















This article is protected by copyright. All rights reserved
6. Kloster S, Tolstrup JS, Olsen MS, Johnsen SP, Sondergaard L, Nielsen DG, et al. Neonatal 
Risk in Children of Women With Congenital Heart Disease: A Cohort Study With Focus 
on Socioeconomic Status. J Am Heart Assoc. 2019; 8:e013491.
7. Statistic Denmark. statistikbanken.dk/FOD11. Available from: 
https://statistikbanken.dk/statbank5a/default.asp?w=1680.
8. Mills M, Rindfuss RR, McDonald P, te Velde E, Reproduction E, Society Task F. Why do 
people postpone parenthood? Reasons and social policy incentives. Human 
Reproduction Update. 2011; 17:848-860.
9. Lean SC, Derricott H, Jones RL, Heazell AEP. Advanced maternal age and adverse 
pregnancy outcomes: A systematic review and meta-analysis. PLoS One. 2017; 
12:e0186287.
10. Heazell AEP, Newman L, Lean SC, Jones RL. Pregnancy outcome in mothers over the age 
of 35. Curr Opin Obstet Gynecol. 2018; 30:337-343.
11. Knudsen LB, Olsen J. The Danish Medical Birth Registry. Danish Medical Bulletin. 1998; 
45:320-323.
12. Bliddal M, Broe A, Pottegard A, Olsen J, Langhoff-Roos J. The Danish Medical Birth 
Register. European Journal of Epidemiology. 2018; 33:27-36.
13. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public 
Health. 2011; 39:30-33.
14. Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, Sorensen HT. The 
Danish National Patient Registry: a review of content, data quality, and research 
potential. Clin Epidemiol. 2015; 7:449-490.
15. Pedersen CB. The Danish Civil Registration System. Scand J Public Health. 2011; 39:22-
25.
16. Schmidt M, Pedersen L, Sorensen HT. The Danish Civil Registration System as a tool in 
epidemiology. European Journal of Epidemiology. 2014; 29:541-549.
17. Olsen M, Garne E, Svaerke C, Sondergaard L, Nissen H, Andersen HO, et al. Cancer risk 
among patients with congenital heart defects: a nationwide follow-up study. Cardiol 
Young. 2014; 24:40-46.
18. Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomstrom-Lundqvist C, Cifkova R, 
De Bonis M, et al. 2018 ESC Guidelines for the management of cardiovascular diseases 















This article is protected by copyright. All rights reserved
19. Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M. A United States national 
reference for fetal growth. Obstet Gynecol. 1996; 87:163-168.
20. Marsal K, Persson PH, Larsen T, Lilja H, Selbing A, Sultan B. Intrauterine growth curves 
based on ultrasonically estimated foetal weights. Acta Paediatrica. 1996; 85:843-848.
21. Statistic Denmark. Invandrere i Danmark 2018 [Internet]. Available from: 
https://www.dst.dk/da/Statistik/Publikationer/VisPub?cid=32561.
22. Morgen CS, Bjork C, Andersen PK, Mortensen LH, Nybo Andersen AM. Socioeconomic 
position and the risk of preterm birth--a study within the Danish National Birth Cohort. 
Int J Epidemiol. 2008; 37:1109-1120.
23. Bilsteen JF, Andresen JB, Mortensen LH, Hansen AV, Andersen AN. Educational 
disparities in perinatal health in Denmark in the first decade of the 21st century: a 
register-based cohort study. BMJ Open. 2018; 8:e023531.
24. Jensen VM, Rasmussen AW. Danish Education Registers. Scand J Public Health. 2011; 
39:91-94.
25. Li R, Chambless L. Test for additive interaction in proportional hazards models. Annals 
of Epidemiology. 2007; 17:227-236.
26. Lawlor DA, Mortensen L, Andersen AM. Mechanisms underlying the associations of 
maternal age with adverse perinatal outcomes: a sibling study of 264 695 Danish 
women and their firstborn offspring. Int J Epidemiol. 2011; 40:1205-1214.
27. Drenthen W, Pieper PG, Roos-Hesselink JW, van Lottum WA, Voors AA, Mulder BJ, et al. 
Outcome of pregnancy in women with congenital heart disease: a literature review. J 
Am Coll Cardiol. 2007; 49:2303-2311.
28. Furenas E, Eriksson P, Wennerholm UB, Dellborg M. Effect of maternal age and cardiac 
disease severity on outcome of pregnancy in women with congenital heart disease. Int J 
Cardiol. 2017; 243:197-203.
29. Bonnet V, Simonet T, Labombarda F, Dolley P, Milliez P, Dreyfus M, et al. Neonatal and 
maternal outcomes of pregnancy with maternal cardiac disease (the NORMANDY study) 
: Years 2000-2014. Anaesth Crit Care Pain Med. 2018; 37:61-65.
30. Goisis A, Schneider DC, Myrskyla M. Secular changes in the association between 
advanced maternal age and the risk of low birth weight: A cross-cohort comparison in 















This article is protected by copyright. All rights reserved
31. Nybo Andersen AM, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and 
fetal loss: population based register linkage study. BMJ. 2000; 320:1708-1712.
32. Fuchs F, Monet B, Ducruet T, Chaillet N, Audibert F. Effect of maternal age on the risk of 
preterm birth: A large cohort study. PLoS One. 2018; 13:e0191002.
33. Pieper PG, Balci A, Aarnoudse JG, Kampman MA, Sollie KM, Groen H, et al. 
Uteroplacental blood flow, cardiac function, and pregnancy outcome in women with 
congenital heart disease. Circulation. 2013; 128:2478-2487.
34. Kampman MA, Balci A, Groen H, van Dijk AP, Roos-Hesselink JW, van Melle JP, et al. 
Cardiac function and cardiac events 1-year postpartum in women with congenital heart 
disease. Am Heart J. 2015; 169:298-304.
35. Josefsson A, Kernell K, Nielsen NE, Bladh M, Sydsjo G. Reproductive patterns and 
pregnancy outcomes in women with congenital heart disease--a Swedish population-
based study. Acta Obstet Gynecol Scand. 2011; 90:659-665.
36. Hayward RM, Foster E, Tseng ZH. Maternal and Fetal Outcomes of Admission for 
Delivery in Women With Congenital Heart Disease. JAMA Cardiol. 2017; 2:664-671.
37. Rosenwein S.V SA, Holmberg T, Michelsen S.I, Tjørnhøj-Thomsen T. Ungdomslivet med 
en hjertesygdom2019.
38. Boivin J, Buntin L, Kalebic N, Harrison C. What makes people ready to conceive? 
Findings from the International Fertility Decision-Making Study. Reprod Biomed Soc 
Online. 2018; 6:90-101.
FUNDING 
The study was funded by the Danish Heart Foundation. Funders had no influence on study 



















This article is protected by copyright. All rights reserved
Figure 2. HRs of preterm birth (upper) and small for gestational age (lower) among women 
with and without congenital heart disease (CHD) at different maternal ages. To the left the 
combined effect of CHD and maternal age is shown using a universal reference group 
(women without CHD aged 25-29 years). To the right comparison is made within women 
with and without CHD. Comparison is made to women aged 25-29 years. Adjusted for parity, 
ethnicity, level of education, and year of inclusion









N % N %
Age 929,084 3,688
Median (IQR) 30 (26-33) 29 (25-32)
15-24 130,747 14.1 752 20.4
25-29 327,656 35.3 1,308 35.5
30-34 324,464 34.9 1,172 31.8
35-39 127,675 13.7 397 10.7
40-44 18,542 2.0 59 1.6
Missing 0 0
Parity 916,892 3,645
0 401,787 43.8 1,752 48.1
1 354,954 38.7 1,326 36.4
≥2 160,151 17.5 567 15.5
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Western 916,852 98.7 3,613 98.0
Non-western 12,232 1.3 75 2.0
Missing 0 0
Education 918,200 3,643
Low (Primary/secondary) 143,320 15.7 758 20.8
Medium (Upper 
secondary/postsecondary)
360,896 39.3 1,373 37.7
Short/medium cycle higher 
education
304,507 33.1 1,131 31.0
Long cycle higher education 109,477 11.9 381 10.5
Missing 10,884 1.2 45 1.2
Year 929,084 3,688
1996-2000 260,058 28.0 812 22.0
2001-2005 265,390 28.6 945 25.6
2006-2010 258,442 27.8 1,166 31.6
2011-2014 145,194 15.6 765 20.8
Missing 0 0
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